Skip to main content

Table 5 One-way sensitivity analysis (minimum values in order to be the most cost-effective option to control joint pain)

From: Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors

  

Type of dominance

  

Extended*

Absolute

Celecoxib

   

Control joint pain

↓

44.0%

 

Control joint pain without adverse events

↓

41.0%

 

Nonselective NSAIDs

   

Control joint pain

↑

67.5%

82.5%

Control joint pain without adverse events

↑

49.5%

63.0%

Acetaminophen

   

Control joint pain

↑

48.0%

55.0%

Control joint pain without adverse events

↑

94.0%

it is not feasible

  1. NSAIDs, nonsteroidal anti-inflammatory drugs.
  2. Extended dominance is defined as the set of all possible mixed therapeutic strategies that dominates a unique strategy in both higher effectiveness and less cost [67].